The market for oncology small molecule drugs is envisaged to register ~6% CAGR through 2029, primarily driven by rapid technological advancement in healthcare sector that continues [read full press release…]
The market for oncology small molecule drugs is envisaged to register ~6% CAGR through 2029, primarily driven by rapid technological advancement in healthcare sector that continues [read full press release…]
The global oncology small molecule drugs market reached ~US$ 66 Mn in 2019 and is anticipated grow at a CAGR of 6% over the forecast [read full press release…]
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global yellow oyster mushroom market as well [read full press release…]
The study assesses macro and microeconomic factors that define the growth prospects of the MRI-guided radiation therapy systems market. It finds that leading players in [read full press release…]
The oncology small molecule drugs market is growing in parallel with the increasing collaborative efforts and initiatives of biopharma companies, investing in early cancer diagnosis [read full press release…]
Rockville Pike, United States, 2019-Sep-25 — /EPR Network/ — According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to surpass [read full press release…]
Rockville Pike, United States, 2019-Sep-06 — /EPR Network/ — According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to [read full press release…]
According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to surpass US$ ~66 Bn in 2019, up from revenues [read full press release…]
According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to surpass US$ ~66 Bn in 2019, up from revenues [read full press release…]
